BRAF and melanoma: In summary, this is the first study to demonstrate that melanoma patients harbor mutations in RPS27. At a mutation rate of ~10%, RPS27 is ranked as the fourth most frequent gene with recurrent mutations identified in melanoma (ranked order: TERT, BRAF, NRAS, RPS27, RAC1).